Found 20 results
Author Keyword [ Title(Desc)] Type Year
Filters: Keyword is Neoplasms  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Frei B, McCall MR.  2001.  Antioxidant vitamins: evidence from biomarkers in humans.. Bibl Nutr Dieta. (55):46-67.
C
McQuistan TJ, Simonich MT, M Pratt M, Pereira CB, Hendricks JD, Dashwood RH, Williams DE, Bailey GS.  2012.  Cancer chemoprevention by dietary chlorophylls: a 12,000-animal dose-dose matrix biomarker and tumor study.. Food Chem Toxicol. 50(2):341-52.
Myzak MC, Dashwood RH.  2006.  Chemoprotection by sulforaphane: keep one eye beyond Keap1.. Cancer Lett. 233(2):208-18.
Higdon JV, Delage B, Williams DE, Dashwood RH.  2007.  Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis.. Pharmacol Res. 55(3):224-36.
D
Dashwood RH, Ho E.  2008.  Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates.. Nutr Rev. 66 Suppl 1:S36-8.
F
Dashwood RH.  2007.  Frontiers in polyphenols and cancer prevention.. J Nutr. 137(1 Suppl):267S-269S.
H
Myzak MC, Dashwood RH.  2006.  Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane.. Curr Drug Targets. 7(4):443-52.
M
Rajendran P, Williams DE, Ho E, Dashwood RH.  2011.  Metabolism as a key to histone deacetylase inhibition.. Crit Rev Biochem Mol Biol. 46(3):181-99.
Parasramka MA, Ho E, Williams DE, Dashwood RH.  2012.  MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals.. Mol Carcinog. 51(3):213-30.
Chen Y-S, Wang R, Dashwood W-M, Löhr CV, Williams DE, Ho E, Mertens-Talcott S, Dashwood RH.  2017.  A miRNA signature for an environmental heterocyclic amine defined by a multi-organ carcinogenicity bioassay in the rat.. Arch Toxicol. 91(10):3415-3425.
Nian H, Delage B, Ho E, Dashwood RH.  2009.  Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.. Environ Mol Mutagen. 50(3):213-21.
P
Cameron E.  1991.  Protocol for the use of vitamin C in the treatment of cancer.. Med Hypotheses. 36(3):190-4.
T
Higdon JV, Frei B.  2003.  Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions.. Crit Rev Food Sci Nutr. 43(1):89-143.
Larsen CA, Dashwood RH, Bisson WH.  2010.  Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.. Pharmacol Res. 62(6):457-64.
Higdon JV, Frei B.  2005.  Is there a gender difference in the effect of antioxidants on cancer risk? Br J Nutr. 94(2):139-40.
Carr AC, Frei B.  1999.  Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans.. Am J Clin Nutr. 69(6):1086-107.
V
Frei B, Lawson S.  2008.  Vitamin C and cancer revisited.. Proc Natl Acad Sci U S A. 105(32):11037-8.
Traber MG, Stevens JF.  2011.  Vitamins C and E: beneficial effects from a mechanistic perspective.. Free Radic Biol Med. 51(5):1000-13.
X
Dashwood RH.  2006.  Xenobiotic metabolism relevance to cancer.. J Nutr. 136(10):2681S-2S.
Z
Ho E.  2004.  Zinc deficiency, DNA damage and cancer risk.. J Nutr Biochem. 15(10):572-8.